about
The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reductionStrategies to improve anxiety and depression in patients with COPD: a mental health perspectiveRoflumilast: a review of its use in the treatment of COPDThe mechanisms of cachexia underlying muscle dysfunction in COPDReview of electronic cigarettes as tobacco cigarette substitutes: Their potential human health impactAdiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityMetabolic syndrome and associated factors in people with chronic obstructive pulmonary disease.A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.Evaluation of von Willebrand factor in COPD patients.The link between chronic periodontitis and COPD: a common role for the neutrophil?Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severityBayesian predictors of very poor health related quality of life and mortality in patients with COPD.The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD).Comorbidities and burden of COPD: a population based case-control study.Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and Nutrition Examination Survey.Is inflammatory chronic obstructive pulmonary disease a coronary heart disease risk equivalent? A longitudinal analysis of the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994.Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study.Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?A simple and rapid method for standard preparation of gas phase extract of cigarette smoke.Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metricsThe pathogenesis of COPD and IPF: distinct horns of the same devil?Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.Multimorbidity and Its Patterns according to Immigrant Origin. A Nationwide Register-Based Study in NorwayComorbidities of chronic obstructive pulmonary disease in Koreans: a population-based studyAdipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary DiseaseTNF-α is associated with loss of lean body mass only in already cachectic COPD patientsThe role of social support in anxiety for persons with COPD.Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceC-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study.Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.Asthma Is Associated With a Subsequent Risk of Peripheral Artery Disease: A Longitudinal Population-Based StudyThe relation of circulating YKL-40 to levels and decline of lung function in adult life.Angiopoietin-like protein 4 and cardiovascular function in COPD.Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study.Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease.Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.
P2860
Q26747185-C1B7A31F-884A-4190-848F-3BE7FBF2E35DQ26765315-6B794B2C-8FAA-4541-84ED-717889720244Q26770501-6D5BC7BD-EA18-463F-9F9C-D67A2974C3CEQ26828616-9F2640AB-F11B-402A-BF03-CB7A8BDE3EE2Q28278622-F45CEF4F-378D-414E-B426-580D4FDE68A6Q28390687-503EEA69-99C6-49EA-97A4-395710C3FC59Q28728578-B9FF44E7-3A50-4775-AC24-768371DD007FQ33652576-AEB98704-6BBD-471E-8061-967E6F0CA910Q34193524-6BC0CA7E-3843-41F9-98B4-4B2C06A7D4F4Q34360211-863368A5-5726-4649-8232-2D89B1CB034BQ34478144-5937AD5F-D378-42C9-A8B3-8104960A68B2Q34611437-6E41CE30-F681-4D73-9D7F-36CD96785CE4Q34621660-E0C8A21B-7A52-4110-BB70-33102D9EFB68Q34700195-8F914776-BFCB-4CEB-9530-814BABDA749AQ34730130-95F63AE3-21A6-4DCB-8C49-4E576D8C8CBFQ35144298-71243340-D28F-4198-9DE5-07543FBAF19CQ35189528-FAE9A4E6-E6D4-4A15-A670-51143ACDBFABQ35215089-C9127380-283A-4A08-A898-3FB8715DBA6AQ35240244-CCC6C5EA-8933-4F0C-9A87-2B870CF122DDQ35258448-5A9BEDC4-9B9D-4107-9B78-7C7F24732C87Q35556719-D3D5B097-0F3C-46AA-B68D-F5B4EE43A4C0Q35766351-5232F6E8-D490-414E-AE77-845D4E8A5BECQ35835036-DB553B81-24E6-4168-8DFE-807E92C89B68Q35873272-2AD2CF47-9E44-4994-A577-6E0D37E068B7Q36134602-CC22CCBB-1991-423F-B162-DCC4C77428A1Q36194869-FC1830BA-2B14-4964-AEE4-3E8F980AE8FFQ36367744-4CD6ADDD-3290-4BE2-B72E-260DF9FA3B4EQ36554257-B9075A91-645B-4FBF-A60B-2DEC470268ACQ36567237-3DD59534-9190-49F7-A7D2-E53D43B6A419Q36953097-F850C72D-26D2-4164-9863-2C11E59FC81BQ37007407-594D2E49-148D-426B-B421-A5EB2E07C335Q37204973-329A1788-0BBF-4322-8A27-C179D97254C0Q37395897-C8761F66-0C22-464A-BC75-6ACD4F860C12Q37464058-046B9E08-091E-4A76-B097-9051D1A34F15Q37572359-FA76B6CE-62D2-4BEE-8A8A-64447E42A678Q37675233-10336DBE-58EC-4767-8DA8-E1CE95CA4455Q38023517-44FA2B9E-4D4A-4061-9F87-E25B0DA3FE48Q38100840-0BA365C2-93D4-42C1-AE71-4C03509886C8Q38109057-7DB57AFD-4953-4620-8B4B-47A74597E127Q38192501-DCDDF55D-16B2-46C4-AC88-AE01AF563285
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic manifestations of COPD.
@en
Systemic manifestations of COPD.
@nl
type
label
Systemic manifestations of COPD.
@en
Systemic manifestations of COPD.
@nl
prefLabel
Systemic manifestations of COPD.
@en
Systemic manifestations of COPD.
@nl
P356
P1433
P1476
Systemic manifestations of COPD.
@en
P2093
Klaus F Rabe
P304
P356
10.1378/CHEST.10-1252
P407
P577
2011-01-01T00:00:00Z